EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

A comparison of fexofenadine/pseudoephedrine and loratadine/montelukast in the treatment of seasonal allergic rhinitis



A comparison of fexofenadine/pseudoephedrine and loratadine/montelukast in the treatment of seasonal allergic rhinitis



Journal of Allergy & Clinical Immunology 111(2 Abstract Supplement): S73, February




(PDF emailed within 1 workday: $29.90)

Accession: 034285755

Download citation: RISBibTeXText



Related references

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology 92(1): 73-79, 2004

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis. Clinical & Experimental Allergy 32(1): 126-132, January, 2002

A comparative study of the side effects between pseudoephedrine in Loratadine plus Pseudoephedrine Sulfate Repetabs Tables and loratadine + pseudoephedrine tablet in treatment of allergic rhinitis in Thai patients. Journal of the Medical Association of Thailand 85(6): 722-727, 2002

Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Allergy and Asthma Proceedings 33(2): E17-E22, 2012

Effects of montelukast , loratadine, montelukast + loratadine and placebo in seasonal allergic rhinitis and conjunctivitis. Journal of Allergy & Clinical Immunology 101(1 PART 2): S97, 1998

Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders. Clinical Therapeutics 22(6): 760-769, 2000

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clinical and Experimental Allergy 30(6): 891-899, 2000

Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clinical & Experimental Allergy 30(6): 891-899, 2000

Sch 434 loratadine 5 mg plus pseudoephedrine 120 mg versus components in the treatment of seasonal allergic rhinitis. Journal of Allergy & Clinical Immunology 81(1): 173, 1988

Efficacy of loratadine compared with fexofenadine or placebo for the treatment of seasonal allergic rhinitis. Clinical Drug Investigation 21(8): 571-578, 2001

Concomitant montelukast and loratadine provide rapid significant improvement in seasonal allergic rhinitis compared with loratadine alone. European Respiratory Journal 12(SUPPL 28): 274S, Sept, 1998

Evaluation of the efficiency and safety of the loratadine with pseudoephedrine combination drug in treatment of seasonal allergic rhinitis. Polski Merkuriusz Lekarski 4(20): 66-68, 1998

Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Archives of Otolaryngology--Head & Neck Surgery 132(2): 164-172, 2006

A comparison of once daily fexofenadine alone or the combination of montelukast plus loratidine on symptoms and nasal peak flow in seasonal allergic rhinitis. Journal of Allergy & Clinical Immunology 107(2): S312-S313, February, 2001

Loratadine and Pseudoephedrine Sulfate: A Double-Blind, Placebo-Controlled Comparison of a Combination Tablet (SCH 434) and Its Individual Components in Seasonal Allergic Rhinitis. American Journal of Rhinology 2(2): 71-75, 1988